Skip to main content

Table 5 Day specific prevalence and intensity of Og4C3 in the three drug groups.

From: Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancroftiin asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study

Day

Prevalence (%)

Mean Intensity of OD valuesa

 

Alb

DEC

Alb + DEC

Alb

DEC

Alb + DEC

0 (pre-therapy)

94.7

88.2

94.1

0.49 (± 0.16)

0.39 (± 0.21)

0.47 (± 0.18)

7

94.7

87.5

88.2

0.47 (± 0.19)

0.40 (± 0.22)

0.44 (± 0.25)

360

15.8**

17.6**

17.6**

0.08** (± 0.17)

0.07** (± 0.15)

0.08** (± 0.15)

  1. a Data are mean ± SD. †P = non significant vs. day 0 (pre-therapy) **P = < 0.01 vs. day 0 (pre-therapy) Alb = albendazole, DEC = diethylcarbamazine citrate, Alb + DEC = albendazole + diethylcarbamazine citrate